Maria Eduarda Cavalcanti Souza

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Endometrial Cancer

Systematic Review

Ejection Fraction

Small Cell Lung Cancer

Top Venues

International journal of colorectal disease

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Luíza Soares de Oliveira Rodrigues, Maria Eduarda Cavalcanti Souza, Francisco Cezar Aquino de Moraes, David Paes de Lima, Rafael Lucas Costa de Carvalho
Talc slurry versus thoracoscopic talc insufflation for malignant pleural effusion: a systematic review and meta-analysis. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 50 (3) (2024)
Francisco Cezar Aquino de Moraes, Francinny Alves Kelly, Maria Eduarda Cavalcanti Souza, Rommel Mario Rodríguez Burbano
Impact of adjuvant chemotherapy on survival after pathological complete response in rectal cancer: a meta-analysis of 31,558 patients. International journal of colorectal disease 39 (1) (2024)
Francisco Cezar Aquino de Moraes, Francinny Alves Kelly, Maria Eduarda Cavalcanti Souza, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos
The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients. BMC cancer 24 (1) (2024)
Francisco Cezar Aquino de Moraes, Francinny Alves Kelly, Maria Eduarda Cavalcanti Souza, Rommel Mario Rodríguez Burbano
Impact of adjuvant chemotherapy on survival after pathological complete response in rectal cancer: a meta-analysis of 31,558 patients. International journal of colorectal disease 39 (1) (2024)
Francisco Cezar Aquino de Moraes, Francinny Alves Kelly, Maria Eduarda Cavalcanti Souza, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos
The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients. BMC cancer 24 (1) (2024)
Francisco Cezar Aquino de Moraes, Francinny Alves Kelly, Maria Eduarda Cavalcanti Souza, Rommel Mario Rodríguez Burbano
Impact of adjuvant chemotherapy on survival after pathological complete response in rectal cancer: a meta-analysis of 31,558 patients. International journal of colorectal disease 39 (1) (2024)
Francisco Cezar Aquino de Moraes, Francinny Alves Kelly, Maria Eduarda Cavalcanti Souza, Rommel Mario Rodríguez Burbano
Impact of adjuvant chemotherapy on survival after pathological complete response in rectal cancer: a meta-analysis of 31,558 patients. International journal of colorectal disease 39 (1) (2024)
Francisco Cezar Aquino de Moraes, Maria Eduarda Cavalcanti Souza, Vitor Kendi Tsuchiya Sano, Rachel Arantes Moraes, Ana C Melo
Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Francisco Cezar Aquino de Moraes, Eric Pasqualotto, Lucca Moreira Lopes, Maria Eduarda Cavalcanti Souza, Anna Luíza Soares de Oliveira Rodrigues, Artur Menegaz de Almeida, Carlos Stecca, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos
PD-1/PD-L1 inhibitors plus carboplatin and paclitaxel compared with carboplatin and paclitaxel in primary advanced or recurrent endometrial cancer: a systematic review and meta-analysis of randomized clinical trials. BMC cancer 23 (1) (2023)
Eric Pasqualotto, Francisco Cezar Aquino de Moraes, Matheus Pedrotti Chavez, Maria Eduarda Cavalcanti Souza, Anna Luíza Soares de Oliveira Rodrigues, Rafael Oliva Morgado Ferreira, Lucca Moreira Lopes, Artur Menegaz de Almeida, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos
PD-1/PD-L1 Inhibitors plus Chemotherapy Versus Chemotherapy Alone for Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers 15 (21) (2023)